Drugs / Gut-X-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07591727 | Aug 2026 → May 2027 expected | Alzheimer disease | Beijing Tiantan Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gut-X-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07591727 ↗ |
| Route | Oral | “Participants will receive Gut-X-001 orally at a dose of 2 active capsules” NCT07591727 ↗ |